Beam Therapeutics Inc

XNAS:BEAM 11:39:07 AM EDT

24.32

-0.86 (-3.40%)

Market Cap (Intraday)	2.51B
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$8.75 Million
Adjusted EPS	-$1.15

See more estimates

10-Day MA	$27.49
50-Day MA	$28.80
200-Day MA	$28.59

See more pivots

Beam Therapeutics Inc Stock, XNAS:BEAM

238 Main Street, 9th floor, Cambridge, Massachusetts 02142-1016

United States of America

Phone: +1.857.327.8775

Number of Employees: 483

http://www.beamtx.com

Description

Beam Therapeutics, Inc. is a biotechnology company, which engages in the establishment of integrated platform for precision genetic medicines. Its pipeline includes BEAM-101, BEAM-302, Engineered Stem Cell Antibody Paired Evasion (ESCAPE), BEAM-301, and BEAM-201. The company was founded by David R. Liu, Feng Zhang, Alexis Komor, Nicole Gaudelli, and J. Keith Joung on January 25, 2017 and is headquartered in Cambridge, MA.